Summary by Futu AI
Innovent bio pharmaceutical co., ltd. announced that it will hold a board of directors meeting on August 28, 2024 (Wednesday). The main purpose of the meeting is to consider and approve the interim performance report for the six months ending June 30, 2024, as well as its release. The board will also consider whether to recommend the distribution of interim dividends. The meeting will be chaired by Dr. Yu Dechao, the company's chairman and executive director.